Shah Pharmacy Limited - Accounts to registrar - small 16.3d
Shah Pharmacy Limited - Accounts to registrar - small 16.3d
REGISTERED NUMBER: |
FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 30 JUNE 2016 |
FOR |
SHAH PHARMACY LIMITED |
SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 30 JUNE 2016 |
Page |
Company Information | 1 |
Chartered Accountants' Report | 2 |
Balance Sheet | 3 |
Notes to the Financial Statements | 5 |
SHAH PHARMACY LIMITED |
COMPANY INFORMATION |
FOR THE YEAR ENDED 30 JUNE 2016 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Chartered Accountants |
505 Pinner Road |
Harrow |
Middlesex |
HA2 6EH |
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS |
ON THE UNAUDITED FINANCIAL STATEMENTS OF |
SHAH PHARMACY LIMITED |
The following reproduces the text of the report prepared for the directors and members in respect of the |
company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is |
only required to file a Balance Sheet. Readers are cautioned that the Statement of Comprehensive Income and |
certain other primary statements and the Report of the Directors are not required to be filed with the Registrar |
of Companies. |
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the |
financial statements of Shah Pharmacy Limited for the year ended 30 June 2016 which comprise the Statement of |
Comprehensive Income, Balance Sheet, and the related notes from the company's accounting records and from |
information and explanations you have given us. |
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance. |
This report is made solely to the Board of Directors of Shah Pharmacy Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Shah Pharmacy Limited and state those matters that we have agreed to state to the Board of Directors of Shah Pharmacy Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Shah Pharmacy Limited Board of Directors, as a body, for our work or for this report. |
It is your duty to ensure that Shah Pharmacy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Shah Pharmacy Limited. You consider that Shah Pharmacy Limited is exempt from the statutory audit requirement for the year. |
We have not been instructed to carry out an audit or a review of the financial statements of Shah Pharmacy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements. |
Chartered Accountants |
505 Pinner Road |
Harrow |
Middlesex |
HA2 6EH |
SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615) |
BALANCE SHEET |
30 JUNE 2016 |
30/6/16 | 30/6/15 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Intangible assets | 4 |
Tangible assets | 5 |
CURRENT ASSETS |
Stocks | 6 |
Debtors | 7 |
Cash at bank and in hand |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
PROVISIONS FOR LIABILITIES | 9 |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615) |
BALANCE SHEET - continued |
30 JUNE 2016 |
In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered. |
The financial statements were approved by the Board of Directors on by: |
SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615) |
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 30 JUNE 2016 |
1. | STATUTORY INFORMATION |
Shah Pharmacy Limited is a |
company's registered number and registered office address can be found on the Company Information page. |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Changes in accounting policies |
This is the first year that the company has presented its financial statements under FRS 102 1A. The last financial |
statements for the year ending 30 June 2015, were prepared under pervious UK GAAP. |
The transition date to FRS 102 1A is 1 July 2015. |
The transition to FRS 102 1A has resulted in certain changes in the accounting policies to those used previously. |
Turnover |
Turnover represents NHS prescription income and counter sales, excluding Value Added Tax. |
Goodwill |
Tangible fixed assets |
Fixtures and fittings | - |
Stocks |
Stocks are measured at the lower of cost and selling price less cost to sell. Cost is calculated on a first in, first out |
basis and includes all costs of purchase, costs of conversion and other costs incurred in bringing the inventories |
to their present location and condition. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences which are differences between taxable profits and |
total comprehensive income that arise from the inclusion of income and expenses in tax assessments in periods |
different from those in which they are recognised in the financial statements. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE YEAR ENDED 30 JUNE 2016 |
4. | INTANGIBLE FIXED ASSETS |
Goodwill |
£ |
COST |
At 1 July 2015 |
and 30 June 2016 |
AMORTISATION |
At 1 July 2015 |
Amortisation for year |
At 30 June 2016 |
NET BOOK VALUE |
At 30 June 2016 |
At 30 June 2015 |
5. | TANGIBLE FIXED ASSETS |
Fixtures |
and |
fittings |
£ |
COST |
At 1 July 2015 |
Additions |
At 30 June 2016 |
DEPRECIATION |
At 1 July 2015 |
Charge for year |
At 30 June 2016 |
NET BOOK VALUE |
At 30 June 2016 |
At 30 June 2015 |
6. | STOCKS |
30/6/16 | 30/6/15 |
£ | £ |
Stocks |
SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE YEAR ENDED 30 JUNE 2016 |
7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30/6/16 | 30/6/15 |
£ | £ |
Trade debtors |
VAT |
Deferred tax asset |
Prepayments |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30/6/16 | 30/6/15 |
£ | £ |
Trade creditors |
Tax |
Social security and other taxes |
Other creditors |
Wages control | 3,944 | - |
Directors' current accounts | 101,454 | 111,661 |
Directors' loan accounts | 300,000 | 400,000 |
Accrued expenses |
9. | PROVISIONS FOR LIABILITIES |
30/6/16 |
£ |
Deferred tax | 977 |
Deferred |
tax |
£ |
Balance at 1 July 2015 | ( |
) |
Provided during year |
Balance at 30 June 2016 |
10. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
During the year company made dividend payment of £30,000 (2015 £30,000) to the shareholders. |
Included in creditors amounts following due after more than one year is a balance of £300,000 (2015 : £400,000) |
for Mr A Shah, a director of the company. |
11. | ULTIMATE CONTROLLING PARTY |
The company is jointly controlled by the directors, who also own 100% of the issued share capital. |